How Many Americans Use GLP 1 Medications
Millions of Americans now use GLP 1 receptor agonist medications. As of recent estimates, tens of millions of prescriptions are filled each year in the United States for drugs like semaglutide and liraglutide. Exact patient counts vary by source, but the user base has grown rapidly in the past several years.
GLP 1 Prescription and Patient Trends
Prescribing data shows a sharp increase in GLP 1 use for both diabetes and weight management. In 2023 and 2024, supply constraints and high demand led to periodic shortages. Real-world claims data and pharmacy reports indicate that the number of Americans on GLP 1 therapy continues to climb, especially among adults with obesity or type 2 diabetes.
Who Is Taking GLP 1 Drugs in the U.S.
GLP 1 medications are used by a broad range of adults, including those with type 2 diabetes, overweight or obesity, and cardiovascular risk factors. Use is higher among older adults and women, but rates are rising across age groups. For the latest figures, see the latest CDC and IQVIA reports on GLP 1 utilization.
